These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 21789003

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Concurrent chemoradiotherapy in adjuvant treatment of breast cancer.
    Ismaili N, Mellas N, Masbah O, Elmajjaoui S, Arifi S, Bekkouch I, Ahid S, Bazid Z, Tazi MA, Erraki A, El Mesbahi O, Benjaafar N, El Gueddari Bel K, Ismaili M, Afqir S, Errihani H.
    Radiat Oncol; 2009 Apr 07; 4():12. PubMed ID: 19351405
    [Abstract] [Full Text] [Related]

  • 3. Randomized controlled trial of late-course concurrent versus sequential chemoradiotherapy after mastectomy and axillary surgery in locally advanced breast cancer.
    Lu Y, Huang H, Yang H, Chen D.
    Medicine (Baltimore); 2017 Oct 07; 96(41):e8252. PubMed ID: 29019894
    [Abstract] [Full Text] [Related]

  • 4. Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for breast carcinoma: a well tolerated adjuvant regimen.
    Isaac N, Panzarella T, Lau A, Mayers C, Kirkbride P, Tannock IF, Vallis KA.
    Cancer; 2002 Aug 15; 95(4):696-703. PubMed ID: 12209711
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patients. a prospective, comparative, non-randomised study.
    Fiets WE, van Helvoirt RP, Nortier JW, van der Tweel I, Struikmans H.
    Eur J Cancer; 2003 May 15; 39(8):1081-8. PubMed ID: 12736107
    [Abstract] [Full Text] [Related]

  • 7. Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer. International Breast Cancer Study Group.
    Wallgren A, Bernier J, Gelber RD, Goldhirsch A, Roncadin M, Joseph D, Castiglione-Gertsch M.
    Int J Radiat Oncol Biol Phys; 1996 Jul 01; 35(4):649-59. PubMed ID: 8690630
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Postmastectomy radiotherapy and concomitant adjuvant chemotherapy versus adjuvant chemotherapy alone in premenopausal breast cancer patients with positive axillary nodes.
    Micheletti E, La Face B, Huscher A, Catalano G, Ambrosi E, Marini G, Simoncini E.
    Tumori; 1998 Jul 01; 84(6):652-8. PubMed ID: 10080670
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
    Fowble B, Hanlon AL, Patchefsky A, Freedman G, Hoffman JP, Sigurdson ER, Goldstein LJ.
    Int J Radiat Oncol Biol Phys; 1998 Aug 01; 42(1):105-15. PubMed ID: 9747827
    [Abstract] [Full Text] [Related]

  • 12. Concurrent vs sequential adjuvant chemotherapy and hormone therapy in breast cancer: a multicenter randomized phase III trial.
    Bedognetti D, Sertoli MR, Pronzato P, Del Mastro L, Venturini M, Taveggia P, Zanardi E, Siffredi G, Pastorino S, Queirolo P, Gardin G, Wang E, Monzeglio C, Boccardo F, Bruzzi P.
    J Natl Cancer Inst; 2011 Oct 19; 103(20):1529-39. PubMed ID: 21921285
    [Abstract] [Full Text] [Related]

  • 13. Feasibility of concurrent adjuvant chemotherapy and radiotherapy after breast-conserving surgery in early breast cancer.
    Han S, Kim J, Sohn S, Kwak GH, Kim JY, Park K.
    J Surg Oncol; 2007 Jan 01; 95(1):45-50. PubMed ID: 17192866
    [Abstract] [Full Text] [Related]

  • 14. Concurrent radiotherapy does not affect adjuvant CMF delivery but is associated with increased toxicity in women with early breast cancer.
    Montemurro F, Gatti M, Redana S, Jacomuzzi ME, Nanni D, Durando A, Popolo M, Ponzone R, Rossi A, Albieri V, Valabrega G, Sismondi P, Gabriele P, Aglietta M.
    J Chemother; 2006 Feb 01; 18(1):90-7. PubMed ID: 16572899
    [Abstract] [Full Text] [Related]

  • 15. Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil.
    Fisher B, Dignam J, Mamounas EP, Costantino JP, Wickerham DL, Redmond C, Wolmark N, Dimitrov NV, Bowman DM, Glass AG, Atkins JN, Abramson N, Sutherland CM, Aron BS, Margolese RG.
    J Clin Oncol; 1996 Jul 01; 14(7):1982-92. PubMed ID: 8683228
    [Abstract] [Full Text] [Related]

  • 16. Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for early breast carcinoma.
    Livi L, Saieva C, Borghesi S, Paoletti L, Meattini I, Rampini A, Petrucci A, Scoccianti S, Paiar F, Cataliotti L, Leonulli BG, Bianchi S, Biti GP.
    Int J Radiat Oncol Biol Phys; 2008 Jul 01; 71(3):705-9. PubMed ID: 18191333
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial.
    Toledano A, Azria D, Garaud P, Fourquet A, Serin D, Bosset JF, Miny-Buffet J, Favre A, Le Floch O, Calais G.
    J Clin Oncol; 2007 Feb 01; 25(4):405-10. PubMed ID: 17264336
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.